HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Huang Selected Research

Esophageal Squamous Cell Carcinoma

1/2024Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial.
1/2024circular RNA circ-231 promotes protein biogenesis of TPI1 and PRDX6 through mediating the interaction of eIF4A3 with STAU1 to facilitate unwinding of secondary structure in 5' UTR, enhancing progression of human esophageal squamous cell carcinoma (ESCC).
12/2023Do higher radiation doses improve survival for cervical esophageal squamous cell cancer patients treated with definitive chemoradiotherapy using intensity-modulated radiotherapy? A propensity-score matched analysis.
4/2023A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy.
2/2023Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study.
8/2022Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study.
4/2022PD-1 inhibitor monotherapy versus combination therapy: A real-world study of patients with recurrent or metastatic advanced esophageal squamous cell carcinoma after first-line chemotherapy.
1/2022Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
11/20213D Deep Learning Model for the Pretreatment Evaluation of Treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
11/2021RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Huang Research Topics

Disease

750Neoplasms (Cancer)
08/2024 - 04/2002
169Inflammation (Inflammations)
05/2024 - 01/2005
113Breast Neoplasms (Breast Cancer)
05/2024 - 08/2004
101Infections
12/2024 - 01/2003
94Neoplasm Metastasis (Metastasis)
08/2024 - 12/2003
71Carcinogenesis
04/2024 - 04/2003
71Pancreatitis
12/2023 - 01/2012
68Hypoxia (Hypoxemia)
01/2024 - 07/2003
67Prostatic Neoplasms (Prostate Cancer)
12/2023 - 11/2005
59Hepatocellular Carcinoma (Hepatoma)
05/2024 - 02/2004
53Obesity
04/2024 - 01/2008
49Lung Neoplasms (Lung Cancer)
08/2024 - 03/2003
47Pain (Aches)
05/2024 - 05/2010
41Fibrosis (Cirrhosis)
12/2024 - 06/2008
39Myocardial Infarction
05/2024 - 02/2009
38Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 08/2006
37Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 11/2010
36Carcinoma (Carcinomatosis)
05/2024 - 04/2003
35Insulin Resistance
04/2024 - 06/2008
35Wounds and Injuries (Trauma)
04/2024 - 11/2008
33Hemorrhage
04/2024 - 04/2010
33Sepsis (Septicemia)
03/2024 - 01/2014
32COVID-19
04/2024 - 01/2020
32Necrosis
04/2024 - 01/2005
30Body Weight (Weight, Body)
09/2023 - 07/2008
29Stomach Neoplasms (Stomach Cancer)
04/2024 - 06/2007
29Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 11/2010
29Atherosclerosis
01/2024 - 09/2002
26Melanoma (Melanoma, Malignant)
04/2024 - 02/2009
26Type 2 Diabetes Mellitus (MODY)
12/2023 - 09/2003
25Glioma (Gliomas)
04/2024 - 06/2003
25Osteoarthritis
02/2024 - 07/2018
25Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 08/2008
24Heart Failure
02/2024 - 02/2006
24Alzheimer Disease (Alzheimer's Disease)
02/2024 - 11/2002
24Esophageal Squamous Cell Carcinoma
01/2024 - 12/2009
23Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 04/2002
23Hypertension (High Blood Pressure)
02/2024 - 08/2006
22Infarction (Infarctions)
02/2024 - 02/2009
21Ischemia
04/2024 - 08/2007
21Colonic Neoplasms (Colon Cancer)
04/2024 - 01/2018
21Leukemia
01/2023 - 05/2002
20Parkinson Disease (Parkinson's Disease)
12/2023 - 08/2002
19Non-alcoholic Fatty Liver Disease
02/2024 - 01/2009
19Endometriosis
12/2023 - 04/2011
19Nasopharyngeal Carcinoma
08/2023 - 01/2006
19Rheumatoid Arthritis
04/2023 - 08/2003
18Adenocarcinoma
03/2024 - 08/2008

Drug/Important Bio-Agent (IBA)

224Proteins (Proteins, Gene)FDA Link
04/2024 - 04/2002
140Biomarkers (Surrogate Marker)IBA
04/2024 - 11/2002
79Messenger RNA (mRNA)IBA
01/2024 - 04/2002
61MicroRNAs (MicroRNA)IBA
11/2023 - 02/2010
58RNA (Ribonucleic Acid)IBA
01/2024 - 06/2004
56EnzymesIBA
02/2024 - 12/2002
56CytokinesIBA
01/2024 - 10/2007
52Therapeutic UsesIBA
04/2024 - 11/2010
48Glucose (Dextrose)FDA LinkGeneric
01/2024 - 04/2002
45LipidsIBA
05/2024 - 07/2006
42Peptides (Polypeptides)IBA
04/2024 - 12/2003
42DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2002
371-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2024 - 01/2016
37Oxygen (Dioxygen)IBA
03/2024 - 06/2008
37Long Noncoding RNAIBA
12/2023 - 09/2016
35Small Interfering RNA (siRNA)IBA
02/2024 - 02/2009
30Phosphotransferases (Kinase)IBA
11/2023 - 12/2003
29Interleukin-6 (Interleukin 6)IBA
12/2023 - 06/2008
28PolymersIBA
03/2024 - 01/2014
28Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 01/2004
28Insulin (Novolin)FDA Link
01/2024 - 01/2009
26Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 10/2010
26Immune Checkpoint InhibitorsIBA
04/2024 - 01/2018
26CholesterolIBA
04/2024 - 09/2002
26Triglycerides (Triacylglycerol)IBA
04/2024 - 04/2006
25HydrogelsIBA
08/2024 - 01/2017
25Histones (Histone)IBA
01/2024 - 08/2004
25C-Reactive ProteinIBA
01/2024 - 08/2006
23LigandsIBA
05/2024 - 08/2002
23Photosensitizing Agents (Photosensitizers)IBA
03/2024 - 02/2015
23Hormones (Hormone)IBA
02/2024 - 11/2008
22Circular RNAIBA
04/2024 - 01/2018
22Indicators and Reagents (Reagents)IBA
01/2024 - 03/2005
22AntigensIBA
12/2023 - 08/2003
22Doxorubicin (Adriamycin)FDA LinkGeneric
05/2023 - 05/2009
19AntioxidantsIBA
02/2024 - 01/2013
19Caspase 3 (Caspase-3)IBA
12/2023 - 01/2013
19VaccinesIBA
11/2023 - 07/2005
18Cisplatin (Platino)FDA LinkGeneric
04/2024 - 12/2009

Therapy/Procedure

373Therapeutics
05/2024 - 05/2002
97Drug Therapy (Chemotherapy)
04/2024 - 12/2003
59Radiotherapy
04/2024 - 10/2008
56Immunotherapy
05/2024 - 06/2003
41Photochemotherapy (Photodynamic Therapy)
03/2024 - 01/2016
34Photothermal Therapy
02/2024 - 10/2017
31Lasers (Laser)
01/2024 - 03/2006
30Precision Medicine
08/2024 - 01/2016
27Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 02/2011
24Chemoradiotherapy
04/2024 - 08/2010
24Stents
01/2024 - 02/2009
23Length of Stay
03/2024 - 06/2012
21Phototherapy (Light Therapy)
04/2024 - 02/2017